Quotes

“This fourth Canada Excellence Research Chair to be awarded to Université Laval and will establish a one-of-a-kind research program into changes in intestinal microbiota, linking obesity to gastrointestinal function and to cardiometabolic diseases that compromise health. With Vincenzo Di Marzo at the helm, this Chair will also showcase our capacity to address major current social challenges, particularly by developing innovative nutritional and medical strategies.”
Denis Brière, Rector, Université Laval

“With the arrival of Vincenzo Di Marzo at Université Laval, Canada is gaining a world leader in biomolecular chemistry. The Government of Canada is proud to support his promising research, which may one day relieve those suffering from metabolic disorders such as obesity and type 2 diabetes in Canada and around the world.”
The Honourable Kirsty Duncan, Minister of Science

“The Canada Excellence Research Chair Program brings the world’s most prestigious researchers to Canada. Dr. Di Marzo is the first research chair in the world devoted to study how microorganisms in our gut are linked to disease. His research will lead to new discoveries to benefit the people of Quebec and citizens across Canada.”
Jean-Yves Duclos, Minister of Families, Children and Social Development

“Dr. Di Marzo brings to Canada a wealth of experience in metabolic disorders and a proven track record in developing therapies from natural sources. His research will contribute to the development of a burgeoning field in Canada, and help researchers understand a little-known, but hugely important, part of the human body.”
Ted Hewitt, President, Social Sciences and Humanities Research Council, and Chair, CERC Steering Committee

“Over the past five years, enormous advances have been made in our understanding of the connection between gastrointestinal micro-organisms and the brain’s endocannabinoid system. Dr. Di Marzo and his team are working at the cutting edge of this burgeoning area of research and will help to position Canada as a world leader in this field. We are proud to support their efforts, which will ultimately lead to better treatments for a wide range of conditions, including obesity and cardiovascular disease.”
Alain Beaudet, President, Canadian Institutes of Health Research

Source:
Andrée-Anne Stewart, Relations médias, Direction des communications

Université Laval – 418 656-3952 – Cell. : 418 254-3141 andree-anne.stewart@dc.ulaval.ca